Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 97,500 shares at $0.18 ($17K) on 2022-10-13, disclosed to the SEC on 2022-10-17.
Seasonal purchase ($17k) by Chairman and CEO, 10% Owner — this insider has traded EMMA in October in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.18 | 62,500 | $11K | 65.4% |
| 2 | $0.17 | 35,000 | $6K | 34.6% |
| Total | $0.18 avg | 97,500 | $17K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |